SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

URSO, Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.830
AS - Asia 3.494
EU - Europa 1.433
SA - Sud America 660
AF - Africa 128
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 1
Totale 9.556
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.659
SG - Singapore 1.469
CN - Cina 575
IT - Italia 511
BR - Brasile 506
VN - Vietnam 490
HK - Hong Kong 334
DE - Germania 201
GB - Regno Unito 128
JP - Giappone 128
FR - Francia 116
IN - India 99
FI - Finlandia 79
CA - Canada 76
RU - Federazione Russa 75
ID - Indonesia 71
MX - Messico 70
NL - Olanda 69
BD - Bangladesh 48
IQ - Iraq 46
AR - Argentina 42
PL - Polonia 40
AT - Austria 39
ZA - Sudafrica 38
TR - Turchia 33
ES - Italia 31
SE - Svezia 29
CO - Colombia 27
PK - Pakistan 26
VE - Venezuela 24
LT - Lituania 21
EC - Ecuador 20
UA - Ucraina 20
MA - Marocco 18
SA - Arabia Saudita 18
TN - Tunisia 18
IR - Iran 17
BE - Belgio 16
KR - Corea 15
PH - Filippine 15
CL - Cile 14
PY - Paraguay 14
UZ - Uzbekistan 14
EG - Egitto 12
MY - Malesia 12
DZ - Algeria 10
IL - Israele 10
TH - Thailandia 10
AE - Emirati Arabi Uniti 9
CZ - Repubblica Ceca 9
KE - Kenya 9
GR - Grecia 8
AZ - Azerbaigian 7
CR - Costa Rica 7
KG - Kirghizistan 7
PE - Perù 7
AU - Australia 6
TW - Taiwan 6
ET - Etiopia 5
SN - Senegal 5
AO - Angola 4
CY - Cipro 4
HU - Ungheria 4
JO - Giordania 4
QA - Qatar 4
RO - Romania 4
RS - Serbia 4
TT - Trinidad e Tobago 4
BH - Bahrain 3
CH - Svizzera 3
HR - Croazia 3
JM - Giamaica 3
NI - Nicaragua 3
PT - Portogallo 3
SY - Repubblica araba siriana 3
UY - Uruguay 3
AL - Albania 2
BO - Bolivia 2
DK - Danimarca 2
GE - Georgia 2
HN - Honduras 2
IE - Irlanda 2
IS - Islanda 2
MK - Macedonia 2
NG - Nigeria 2
NO - Norvegia 2
NP - Nepal 2
OM - Oman 2
PA - Panama 2
PS - Palestinian Territory 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
TV - Tuvalu 2
AM - Armenia 1
BJ - Benin 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GA - Gabon 1
Totale 9.535
Salva come PNG Salva come JPEG
Città #
Singapore 943
Ashburn 752
San Jose 544
Hong Kong 330
Dallas 329
Santa Clara 248
Beijing 215
New York 155
Council Bluffs 150
Ho Chi Minh City 147
Los Angeles 140
Hanoi 127
Tokyo 119
Lauterbourg 80
Chicago 78
Munich 68
Chandler 60
Hefei 51
Jakarta 51
Milan 47
São Paulo 47
Bologna 46
Orem 42
Ferrara 40
Frankfurt am Main 39
Mexico City 38
Shanghai 38
Atlanta 37
Lappeenranta 37
Buffalo 36
London 34
Warsaw 34
Brooklyn 31
Houston 30
Helsinki 29
Rome 26
The Dalles 26
Montreal 25
Nuremberg 25
Haiphong 24
Denver 23
Phoenix 23
Da Nang 22
Chennai 21
Rio de Janeiro 21
Stockholm 21
Brasília 19
Fairfield 19
Johannesburg 19
Poplar 19
Toronto 19
Salt Lake City 18
Amsterdam 17
Manchester 17
Baghdad 16
Falkenstein 16
Vienna 15
Boston 14
City of London 14
Istanbul 13
Tashkent 13
Turku 13
Dong Ket 12
Elk Grove Village 12
Moscow 12
Mumbai 12
Seattle 12
Asunción 11
Ottawa 11
Boardman 10
Brussels 10
Medellín 10
Porto Alegre 10
Thái Nguyên 10
Wilmington 10
Ankara 9
Nairobi 9
Tampa 9
Assago 8
Belo Horizonte 8
Buriram 8
Dhaka 8
Hải Dương 8
Kansas City 8
Miami 8
Parma 8
San Francisco 8
Caracas 7
Manaus 7
New Delhi 7
Paris 7
Querétaro 7
Quito 7
Riyadh 7
Berlin 6
Biên Hòa 6
Cairo 6
Cambridge 6
Campinas 6
Can Tho 6
Totale 6.036
Salva come PNG Salva come JPEG
Nome #
90 Y/177 Lu‐dotatoc From Preclinical Studies to Application in Humans 221
18F-Choline PET/CT or PET/MR and the evaluation of response to systemic therapy in prostate cancer: are we ready? 219
177Lu-PRRT in advanced gastrointestinal neuroendocrine tumors: 10-year follow-up of the IRST phase II prospective study 208
Atypical Metastases from Prostate Cancer: Alpha-Methylacyl-Coenzyme A Racemase (AMACR) as a Potential Molecular Target in Prostate-Specific Membrane Antigen-Negative Prostate Adenocarcinoma 199
18F-FDG PET/CT radiomic analysis and artificial intelligence to predict pathological complete response after neoadjuvant chemotherapy in breast cancer patients 182
The Role of [68Ga]PSMA PET/CT for Clinical Suspicion of Prostate Cancer in Patients with or without Previous Negative Biopsy: A Systematic Review 182
Glucose Metabolism Modification Induced by Radioligand Therapy with [177Lu]Lu/[90Y]Y-DOTATOC in Advanced Neuroendocrine Neoplasms: A Prospective Pilot Study within FENET-2016 Trial 170
MONTE CARLO SIMULATIONS IN RADIO-LIGAND THERAPY WITH LU-177 FOR NEUROENDOCRINE TUMOURS (NETS) 164
The Role of [18F]F-Choline PET/CT in the Initial Management and Outcome Prediction of Prostate Cancer: A Real-World Experience from a Multidisciplinary Approach 155
ML Models Built Using Clinical Parameters and Radiomic Features Extracted from 18F-Choline PET/CT for the Prediction of Biochemical Recurrence after Metastasis-Directed Therapy in Patients with Oligometastatic Prostate Cancer 153
Clinical-diagnostic relevance of breast “incidentaloma” detected during 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography: Correlation with radiological imaging and histopathology 151
Diverse Imaging Methods May Influence Long-Term Oncologic Outcomes in Oligorecurrent Prostate Cancer Patients Treated with Metastasis-Directed Therapy (the PRECISE-MDT Study) 149
PET Radiomics and Response to Immunotherapy in Lung Cancer: A Systematic Review of the Literature 149
Lutathera® Orphans: State of the Art and Future Application of Radioligand Therapy with 177Lu-DOTATATE 147
The Value of Semiquantitative Parameters Derived from 18F-FDG PET/CT for Predicting Response to Neoadjuvant Chemotherapy in a Cohort of Patients with Different Molecular Subtypes of Breast Cancer 146
Rhenium Radioisotopes for Medicine, a Focus on Production and Applications 145
[18F]FDG PET-TC radiomics and machine learning in the evaluation of prostate incidental uptake 145
Is There a Role for FAPI PET in Urological Cancers? 143
Role of 18F-FDG PET/CT in evaluating lymph node status in patients with head and neck squamous cell carcinoma 143
Advantages of SiPM-based digital PET/CT technology in nuclear medicine clinical practice: a systematic review—Part 1 oncological setting 143
Advantages of SiPM-based digital PET/CT technology in nuclear medicine clinical practice: a systematic review– part 2 141
Positron Emission Tomography-Derived Radiomics and Artificial Intelligence in Multiple Myeloma: State-of-the-Art 141
PET-Derived Radiomics and Artificial Intelligence in Breast Cancer: A Systematic Review 140
Role of PSMA-ligands imaging in Renal Cell Carcinoma management: current status and future perspectives 140
Relevance of Volumetric Parameters Applied to [68Ga]Ga-DOTATOC PET/CT in NET Patients Treated with PRRT 138
68Ga-PSMA-11 PET/CT in Bilateral Clear Cell Renal Cell Carcinoma: an Intra-patient Comparison Between High and Low Grade Tumors 136
Can Baseline [18F]FDG PET/CT Predict Response to Immunotherapy After 6 Months and Overall Survival in Patients with Lung Cancer or Malignant Melanoma? A Multicenter Retrospective Study 135
Uncommon solitary nasal extramedullary plasmacytoma detected by 18F-FDG PET/CT 135
Complicated Inguinal Hernia Incidentally Detected on a Radiolabelled Autologous White Blood Cell Scan 134
Italian Association of Nuclear Medicine, Molecular Imaging and Therapy (AIMN) practical guide for peptide receptor radionuclide therapy (PRRT) with [177Lu]Lu-Oxodotreotide in gastroenteropancreatic neuroendocrine tumors (GEP-NET) 134
PET Criteria by Cancer Type from Imaging Interpretation to Treatment Response Assessment: Beyond FDG PET Score 133
[18F]-FDHT PET for the Imaging of Androgen Receptor in Prostate and Breast Cancer: A Systematic Review 133
18F-FDG PET-Derived Volume-Based Parameters to Predict Disease-Free Survival in Patients with Grade III Breast Cancer of Different Molecular Subtypes Candidates to Neoadjuvant Chemotherapy 133
68Ga-Trivehexin: Current Status of αvβ6-Integrin Imaging and Perspectives 131
99mTc-labeled FAPI compounds for cancer and inflammation: from radiochemistry to the first clinical applications 131
FDG PET/CT Volume-Based Quantitative Data and Survival Analysis in Breast Cancer Patients: A Systematic Review of the Literature 129
Impact on the long-term prognosis of FDG PET/CT in luminal-A and luminal-B breast cancer 126
COMPARISON BETWEEN CLINICAL DOSIMETRIC PLATFORMS IN NET PATIENTS TREATED WITH PRRT 121
Incidental findings of acute myeloid leukemia in Sjögren's syndrome detected by nuclear medicine techniques 121
Cavernous Hepatic Hemangioma at 18F‑Choline Positron Emission Tomography–Computed Tomography: Be Aware of the Pitfall 118
Right Atrium Mass Assessed with 18F-FDG PET/CT Scan Turns Out to Be an Uncommon Relapse of Testicular Diffuse Large B-cell Lymphoma: A Case Report 116
Impact of Metastasis-directed Therapy Guided by Different PET/CT Radiotracers on Distant and Local Disease Control in Oligorecurrent Hormone-sensitive Prostate Cancer: A Secondary Analysis of the PRECISE-MDT Study 110
Superscan-Like Pattern on 18F-Choline PET/CT in a Patient With Essential Thrombocythemia 109
Diagnostic Accuracy of PET with 18F-Fluciclovine ([18F]FACBC) in Detecting High-Grade Gliomas: A Systematic Review and Meta-Analysis 109
A Prospective Randomized Multicenter Study on the Impact of [18F]F-Choline PET/CT Versus Conventional Imaging for Staging Intermediate- to High-Risk Prostate Cancer 108
18 F-Choline Versus 68 Ga-PSMA-11 PET/CT Imaging Comparison in Incidental Clear Cell Renal Cell Carcinoma 106
Misinterpretation of an inflammatory FDG uptake in a patient treated for Hodgkin lymphoma: a case report 106
18F-FDG PET/CT Radiomics for Predicting Therapy Response in Primary Mediastinal B-Cell Lymphoma: A Bi-Centric Pilot Study 105
Radioligand therapy (RLT) as neoadjuvant treatment for inoperable pancreatic neuroendocrine tumors: a literature review 102
Comparison of MRI vs. [18F]FDG PET/CT for Treatment Response Evaluation of Primary Breast Cancer after Neoadjuvant Chemotherapy: Literature Review and Future Perspectives 102
Nectin-4-Targeting Radiotracers: Novel Theranostic Agents for Precision Oncology in Cancer 98
[99mTc]Tc-sestamibi for the differential diagnosis of renal masses: a study protocol 94
Artificial intelligence & nuclear medicine: an emerging partnership 92
The Role of Radiomics and Artificial Intelligence Applied to Staging PSMA PET in Assessing Prostate Cancer Aggressiveness 92
Considerations on the preliminary results of the NETTER-2 trial: is the glass half full or half empty? 91
Radiomics Results for Adrenal Mass Characterization Are Stable and Reproducible Under Different Software 89
Insights into pet-based radiogenomics in oncology: an updated systematic review 88
Radioligand therapy in sympathetic-adrenal-medullary axis tumors: state of art and perspectives 88
ITA-IMMUNO-PET: The Role of [18F]FDG PET/CT for Assessing Response to Immunotherapy in Patients with Some Solid Tumors 81
Extramedullary disease in multiple myeloma: what you might not expect on [18F]FDG PET/CT - a pictorial essay 79
PSMA PET/CT in Castration-Resistant Prostate Cancer: Myth or Reality? 79
Oldie but Goodie: Is Technetium-99m Still a Treasure Trove of Innovation for Medicine? A Patents Analysis (2000-2022) 79
The Role of Radiomics in the Era of Immune Checkpoint Inhibitors: A New Protagonist in the Jungle of Response Criteria 79
Lymphoid organs’ metabolism and its role in predicting the outcomes of patients with malignant melanoma treated with immunotherapy: an exploratory study 77
The impact of PET imaging on triple negative breast cancer: an updated evidence-based perspective 75
The Future Direction of Women in Nuclear Medicine and Nuclear Medicine in Women's Health 75
Clinical applications of long axial field-of-view PET/CT scanners in oncology 74
Prognostic factors in children and adolescents with differentiated thyroid carcinoma treated with total thyroidectomy and RAI: a real-life multicentric study 73
The evolution of PET imaging in renal, bladder, upper urinary tract urothelial, testicular and penile carcinoma - Today's impact, tomorrow's potential 71
Triple Tracer PET in Advanced Prostate Cancer: Chasing Phenotypic Plasticity 71
The Role of Molecular Imaging in Patients with Brain Metastases: A Literature Review 68
Molecular imaging of PARP in cancer: state-of-the-art 68
One scan, many stories: deep learning for signal separation in multi-tracer PET imaging 67
Initial results of the use of a novel semiquantitative parameter in three-phase bone scan to predict 99mTc-HMPAO-labeled leukocyte scintigraphy in patients with unilateral total knee replacement 63
Synthetic imaging for research and education in nuclear medicine: Who’s afraid of the black box? 61
Hepato-Biliary Imaging in an Acute Setting: Is There a Role for Nuclear Medicine? 59
Girentuximab imaging in renal cancer: diamond in the rough or just ZIRCON? 58
Phosphorus-32 microparticles for locally advanced pancreatic cancer: how and when? 57
PARP-Targeted Radiotheranostics with Auger Electrons: An Updated Overview 57
The expanding role of next-generation imaging in prostate cancer management: a cross-sectional survey exploring the clinical practice of uro-oncologists in North-Eastern Italy; on behalf of GUONE (Gruppo Uro-Oncologico del Nord-Est) 57
18 F-FDG PET/CT Volumetric Metabolic Parameters in the Staging of Head and Neck Squamous Cell Carcinoma 55
Radiomics and theranostics with molecular and metabolic probes in prostate cancer: toward a personalized approach 51
Safire CT iterative reconstruction protocol to reduce patient effective dose on PET/CT examinations 50
Targeting Glypican-3 in Liver Cancer: Groundbreaking Preclinical and Clinical Insights 50
Radioligand Therapy with Radiolabeled Somatostatin Analogues in Metastatic Bronchial Carcinoid: an Impressive Response 50
Joint survey by AIMN, AIOM, AIRO, SIU, SIUrO, and Meet-URO about the use of PSMA PET imaging in prostate cancer in Italy: technical aspects and primary staging setting 49
AIMN, ITANET, SIE joint position paper for the recognition, prevention and management of NET carcinoid syndrome and crises during peptide receptor radionuclide therapy 45
Molecular Imaging Advances in Endometriosis: The Promise of Radiopharmaceuticals 44
Radionuclide-based nanotechnologies in triple-negative breast cancer: current evidence and future perspectives 39
Molecular Imaging in Cancer Chemoresistance: What’s Brewing? 37
The Value of FDG PET/CT in Penile Cancer: An Update 27
Real-world, multicenter assessment of 18 F-FDG PET/CT prognostic value in triple-negative breast cancer (TRINE-PET): the study protocol 20
The future of nuclear medicine in Italy 8
Diagnostic accuracy of 18F-FDG PET/CT in muscle-invasive bladder cancer: rationale and design of the MIBC-PET study 7
Illuminating Multiple Sclerosis: Next-Generation PET Tracers for Molecular Insights 7
Emerging need of dosimetry in radioligand therapy: a feasible method tested in a large cohort of patients affected by neuroendocrine neoplasms 3
The value of [18F]FDG PET/CT in fever of unknown origin (FUO): an update and future aspects 2
Totale 9.841
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.756
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.756
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202124 0 0 0 0 0 0 0 0 0 5 1 18
2021/202261 2 0 0 2 5 4 7 2 5 3 15 16
2022/2023186 7 15 3 17 21 20 18 18 14 2 42 9
2023/2024371 11 24 29 14 40 45 12 47 18 12 40 79
2024/20252.312 74 87 190 104 235 144 87 110 369 304 357 251
2025/20266.848 609 308 687 908 979 421 936 440 725 835 0 0
Totale 9.841